No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Concurrent S-1-based chemoradiotherapy improves survival compared to radiotherapy alone in older patients with esophageal cancer

byTeddy Guo

September 9, 2021

in StudyGraphics

Reading Time: 1 min read

Click to read the study in JAMA Oncology.

RELATED REPORTS

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

Study highlights poor outcomes in very preterm infants with early-onset sepsis

RelatedReports

StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

June 19, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

June 4, 2025

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Gastroenterology

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

April 16, 2025

Incidence of esophageal cancer subtypes vary drastically globally and by gender

Chronic Disease

Active Surveillance vs Standard Surgery Post-Neoadjuvant Chemoradiotherapy for Esophageal Cancer

March 24, 2025

#VisualAbstract A multimodal intervention reduced peripheral intravenous catheter failures in hospitalized patients

Perinatal outcomes among patients with sepsis during pregnancy

Colleges can support students with chronic medical conditions

Burnout is associated with reduced academic performance in postsecondary students

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result